Grassley: Finance Committee Will Discuss PBM Transparency Bill
Inside Health Policy
Senate Finance Committee Chairman Sen. Chuck Grassley (R-IA) will discuss a bill on pharmacy benefit manager transparency this session with his committee, a spokesman for the senator told Inside Health Policy…Read More.
As Congress returns, lawmakers rush to detail drug-pricing agendas
Chuck Grassley wasted little time this week in unveiling his drug-pricing agenda, attaching his name to a trio of bills that, as the new chair of the Senate Finance Committee, he is freshly empowered to advance…Read More.
Grassley’s Longtime Focus on Transparency Praised by National LTC Pharmacy Advocacy Group as Senator Assumes Senate Finance Committee Chairmanship
New WSJ Report on Part D Medicare Plans Overcharging CMS Ripe Target for Scrutiny…Read More.
CVS and Aetna complete their merger
One group worries about what it will mean for seniors…Read More.
Completion of CVS Health-Aetna Merger Underscores Importance to Seniors of Scrutinizing Proposed CMS Drug Pricing Rule
National LTC Pharmacy Advocacy Group Warns Health Industry Consolidation Crushing Choice, Competition at Expense of Senior Consumers…Read More.
SCPC Expresses Concern Proposed CMS Rule Threatens Seniors’ Access to Essential Medications, Further Undermines LTC Pharmacy Economic Viability
The Senior Care Pharmacy Coalition (SCPC) today said its initial review of the Centers for Medicare and Medicaid Services (CMS) proposed changes to Medicare Advantage and Part D programs…Read More.
Part D, Rebate-Sharing Rules Slated To Be Proposed This Month
Inside Health Policy
Two rules that are expected to include major policies to curb drug prices are scheduled to be released this month, according to the fall regulatory agenda…Read More.
CVS and Aetna merger a disruptive sign of the future
The proposed CVS Health-Aetna merger is emblematic of the growing arms race to consolidate and control consumer access to appropriate prescription drugs, particularly LTC (long-term care) patients…Read More.
CVS Health-Aetna Merger Emblematic of Growing Arms Race to Consolidate, Control Seniors’ Access to Prescription Drugs
The proposed CVS Health-Aetna merger is emblematic of the growing arms race to consolidate and control consumer access to appropriate prescription drugs, particularly LTC patients…Read More.